MBX Biosciences

MBX Biosciences

Advancing potential breakthrough medicines for endocrine diseases of substantial medical need.

Launch date
Employees
Market cap
€615m
Enterprise valuation
€565m (Public information from Sep 2024)
Carmel Indiana (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD20222023
EBITDA(24.7m)(32.4m)
Profit(26.1m)(32.6m)
R&D budget21.4m28.5m
  • Edit

Recent News about MBX Biosciences

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.